| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 3876 |
| 1 | PREDNISONE | 3549 |
| 2 | METHOTREXATE | 3285 |
| 3 | RITUXIMAB | 2636 |
| 4 | PEMBROLIZUMAB | 2630 |
| 5 | PREDNISOLONE | 2439 |
| 6 | PREDNISOLONE ORAL | 2439 |
| 7 | PREDNISOLONE ORAL SOLUTION | 2439 |
| 8 | FUROSEMIDE | 2123 |
| 9 | CYCLOPHOSPHAMIDE | 1805 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1100 | 0.1008 |
| 1 | TOREMIFENE CITRATE | 22 | 0.0510 |
| 2 | NALDEMEDINE | 81 | 0.0487 |
| 3 | ERIBULIN MESYLATE | 181 | 0.0484 |
| 4 | ANTIBACTERIAL HAND WIPES | 16 | 0.0479 |
| 5 | RAMUCIRUMAB | 301 | 0.0476 |
| 6 | GEFITINIB | 420 | 0.0467 |
| 7 | BORIC ACID | 16 | 0.0451 |
| 8 | BENZALKONIUM CHLORIDE 0.13% | 16 | 0.0426 |
| 9 | GOLD | 236 | 0.0406 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 7739 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5121 |
| 2 | Kinase Inhibitor [EPC] | 4248 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 3741 |
| 4 | Platinum-based Drug [EPC] | 3459 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3382 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 3058 |
| 7 | Proton Pump Inhibitor [EPC] | 2975 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 2924 |
| 9 | Microtubule Inhibitor [EPC] | 2640 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 90 | 0.1308 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5121 | 0.0519 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 301 | 0.0476 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 207 | 0.0354 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 265 | 0.0304 |
| 5 | Lipopeptide Antibacterial [EPC] | 275 | 0.0289 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 596 | 0.0276 |
| 7 | Endoglycosidase [EPC] | 42 | 0.0227 |
| 8 | Provitamin D2 Compound [EPC] | 670 | 0.0225 |
| 9 | l-Thyroxine [EPC] | 1 | 0.0204 |